Mathews Nitty Skariah, Masih Dipti, Mittal Rohin, Perakath Benjamin, Sakthi Dhananjayan, Rebekah Grace, Pai Rekha, Pulimood Anna B
Department of General Pathology, Christian Medical College, Vellore, Tamil Nadu, India.
Department of Colorectal Surgery, Christian Medical College, Vellore, Tamil Nadu, India.
Indian J Cancer. 2019 Oct-Dec;56(4):309-314. doi: 10.4103/ijc.IJC_224_18.
The incidence of colorectal cancers (CRCs) in young Indian patients is higher than the international average. CRCs in young patients are commonly of mucinous type and show microsatellite instability (MSI).
To ascertain the MSI status of mucinous CRCs in patients ≤40 years of age by molecular testing and to correlate this with immunohistochemical (IHC) analysis and tumor histology.
Archived formalin-fixed paraffin embedded tissue blocks of 30 young mucinous CRC patients were retrieved. MSI testing was done using two mononucleotide markers - BAT26 and NR24. IHC analysis was done using MLH1, MSH2, and MSH6. Histological features of all cases were studied. Data were analyzed using the SPSS software and the Pearson's chi-square test and Fisher's exact test.
Eight out of 30 cases (26.7%) showed MSI by molecular testing. IHC identified seven of these cases. Histological features showing a statistically significant association with MSI were the presence of a well-differentiated adenocarcinoma component (P = 0.003), peritumoral lymphocytes (P = 0.002) and tumor budding (P = 0.021).
The detection of defective mismatch repair (MMR) proteins using IHC for MLH1, MSH2, and MSH6 and molecular testing using BAT26 and NR24 appears to be a good protocol to detect CRCs with MSI. Histology could be useful in identifying cases that require screening for presence of MMR protein defects.
印度年轻患者中结直肠癌(CRC)的发病率高于国际平均水平。年轻患者的CRC通常为黏液型,并表现出微卫星不稳定性(MSI)。
通过分子检测确定年龄≤40岁患者黏液性CRC的MSI状态,并将其与免疫组织化学(IHC)分析及肿瘤组织学相关联。
检索30例年轻黏液性CRC患者的存档福尔马林固定石蜡包埋组织块。使用两个单核苷酸标记物——BAT26和NR24进行MSI检测。使用MLH1、MSH2和MSH6进行IHC分析。研究所有病例的组织学特征。使用SPSS软件以及Pearson卡方检验和Fisher精确检验对数据进行分析。
30例病例中有8例(26.7%)通过分子检测显示MSI。IHC鉴定出其中7例。与MSI存在统计学显著关联的组织学特征为存在高分化腺癌成分(P = 0.003)、肿瘤周围淋巴细胞(P = 0.002)和肿瘤芽生(P = 0.021)。
使用针对MLH1、MSH2和MSH6的IHC检测错配修复(MMR)蛋白缺陷以及使用BAT26和NR24进行分子检测似乎是检测具有MSI的CRC的良好方案。组织学有助于识别需要筛查MMR蛋白缺陷的病例。